Pharmaceuticals giant GSK has said it is "unequivocally” committed to its London listing in a soothing sign for the City after a flood of exits from the market this year.
GSK’s share price is down on legal uncertainty over its Zantac drug, but this only makes it more of a bargain, in my view, supported by a strong business. The post Down 11%, is GSK’s share price an unmissable bargain right now? appeared first on The Motley Fool UK.
Charlie Carman explains how he'd build a sizeable passive income portfolio over time by investing a tenner a day in dividend stocks. The post Here’s how investing £10 a day could create passive income of £27,573 a year! appeared first on The Motley Fool UK.